Viewing data from:

CLOMIPRAMINE HYDROCHLORIDE

ANDA

CLOMIPRAMINE HYDROCHLORIDE | A074947 | PHARMOBEDIENT CONSULTING LLC

3 strengths0 unique patents0 unique exclusivities

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

LUNDBECK PHARMACEUTICALS ITALY SPACLOMIPRAMINE HYDROCHLORIDE

DMF 88641990

SIGMA ALDRICH IRELAND LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 109491994

TARO PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 130211998

BIOPHORE INDIA PHARMACEUTICALS PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 308142016

RL FINE CHEM PVT LTDCLOMIPRAMINE HYDROCHLORIDE

DMF 319422017

SUN PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 329962018

MANKIND PHARMA LTDCLOMIPRAMINE HYDROCHLORIDE USP

DMF 349352020

IROPHARM LTDInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 80471989

EVONIK TECHNOCHEMIE GMBHInactiveCLOMIPRAMINE HYDROCHLORIDE

DMF 131271998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 30, 1998	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Apr 30, 1998

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 30, 1998

#003 — 75MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Apr 30, 1998